NCT00191412View on ClinicalTrials.gov

A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

March 31, 2006

Conditions
Liver Cancer
Interventions
DRUG

Pemetrexed

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Denver

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191412 - A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver | Biotech Hunter | Biotech Hunter